Siri Lynne Rydning

Siri Lynne Rydning

Auto-generated profile, based on publicly available information

Siri Lynne Rydning

Department of Neurology, Oslo University Hospital, Oslo, Norway

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ZIZafar Iqbal
Zafar Iqbal
SRSiri L. Rydning
Siri L. Rydning
IWIselin M. Wedding
Iselin M. Wedding
JKJeanette Koht
Jeanette Koht
LPLasse Pihlstrøm
Lasse Pihlstrøm
MTMathias Toft
Mathias Toft
Hereditary ataxia and spastic paraplegia are heterogeneous monogenic neurodegenerative disorders. To date, a large number of individuals with such disorders remain undiagnosed. Here, we have assessed molecular diagnosis by gene panel sequencing in 105 early and late-onset hereditary ataxia and spastic paraplegia probands, in whom extensive previous investigations had failed to identify the genetic cause of disease. Pathogenic and likely-pathogenic variants were identified in 20 probands (19%) and variants of uncertain significance in ten probands (10%). Together these accounted for 30 probands (29%) and involved 18 different genes. Among several interesting findings, dominantly inherited KIF1A variants, p.(Val8Met) and p.(Ile27Thr) segregated in two independent families, both presenting with a pure spastic paraplegia phenotype. Two homozygous missense variants, p.(Gly4230Ser) and p.(Leu4221Val) were found in SACS in one consanguineous family, presenting with spastic ataxia and isolated cerebellar atrophy. The average disease duration in probands with pathogenic and likely-pathogenic variants was 31 years, ranging from 4 to 51 years. In conclusion, this study confirmed and expanded the clinical phenotypes associated with known disease genes. The results demonstrate that gene panel sequencing and similar sequencing approaches can serve as efficient diagnostic tools for different heterogeneous disorders. Early use of such strategies may help to reduce both costs and time of the diagnostic process.

7 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKSukhleen Kour
Sukhleen Kour
DRDeepa S. Rajan
Deepa S. Rajan
TFTyler R. Fortuna
Tyler R. Fortuna
EAEric N. Anderson
Eric N. Anderson
CWCaroline Ward
Caroline Ward
UPUdai Pandey
Udai Pandey
GEMIN5, an RNA-binding protein is essential for assembly of the survival motor neuron (SMN) protein complex and facilitates the formation of small nuclear ribonucleoproteins (snRNPs), the building blocks of spliceosomes. Here, we have identified 30 affected individuals from 22 unrelated families presenting with developmental delay, hypotonia, and cerebellar ataxia harboring biallelic variants in the GEMIN5 gene. Mutations in GEMIN5 perturb the subcellular distribution, stability, and expression of GEMIN5 protein and its interacting partners in patient iPSC-derived neurons, suggesting a potential loss-of-function mechanism. GEMIN5 mutations result in disruption of snRNP complex assembly formation in patient iPSC neurons. Furthermore, knock down of rigor mortis, the fly homolog of human GEMIN5, leads to developmental defects, motor dysfunction, and a reduced lifespan. Interestingly, we observed that GEMIN5 variants disrupt a distinct set of transcripts and pathways as compared to SMA patient neurons, suggesting different molecular pathomechanisms. These findings collectively provide evidence that pathogenic variants in GEMIN5 perturb physiological functions and result in a neurodevelopmental delay and ataxia syndrome.

12 March 2018 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
SRS. L. Rydning
S. L. Rydning
ADA. Dudesek
A. Dudesek
FRF. Rimmele
F. Rimmele
CFC. Funke
C. Funke
SKS. Krüger
S. Krüger
CKChristoph Kamm
Christoph Kamm

9 March 2017 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SRSiri L. Rydning
Siri L. Rydning
PBPaul H. Backe
Paul H. Backe
MSMirta M. L. Sousa
Mirta M. L. Sousa
ZIZafar Iqbal
Zafar Iqbal
AØAne-Marte Øye
Ane-Marte Øye
KSKaja Kristine Selmer
Kaja Kristine Selmer
Human Molecular Genetics, doi: 10.1093/hmg/ddx072 .

7 March 2019 in Brain
Verified
Journal Article
Open access
PDF file
SRSiri L Rydning
Siri L Rydning
JKJeanette Koht
Jeanette Koht
YSYing Sheng
Ying Sheng
PSPiotr Sowa
Piotr Sowa
HHHanne S Hjorthaug
Hanne S Hjorthaug
KSKaja Kristine Selmer
Kaja Kristine Selmer

22 December 2016 in Human Molecular Genetics
Verified
Journal Article
Closed access
SRSiri L. Rydning
Siri L. Rydning
PBPaul H. Backe
Paul H. Backe
MSMirta M. L. Sousa
Mirta M. L. Sousa
ZIZafar Iqbal
Zafar Iqbal
AØAne-Marte Øye
Ane-Marte Øye
KSKaja Kristine Selmer
Kaja Kristine Selmer
Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 has been implicated in early-onset progressive neurodegeneration (MIM no. 615491), so far only in one family. In this study a second family is characterized, and the functional consequences of the identified mutations in UCHL1 are explored. Three siblings developed childhood-onset optic atrophy, followed by spasticity and ataxia. Whole exome sequencing identified compound heterozygous variants in UCHL1, c.533G > A (p.Arg178Gln) and c.647C > A (p.Ala216Asp), cosegregating with the phenotype. Enzymatic activity of purified recombinant proteins analysed by ubiquitin hydrolase assays showed a 4-fold increased hydrolytic activity of the recombinant UCHL1 mutant Arg178Gln compared to wild type, whereas the Ala216Asp protein was insoluble. Structural 3D analysis of UCHL1 by computer modelling suggests that Arg178 is a rate-controlling residue in catalysis which is partly abolished in the Arg178Gln mutant and, consequently, the Arg178Gln mutant increases the enzymatic turnover. UCHL1 protein levels in fibroblasts measured by targeted mass spectrometry showed a total amount of UCHL1 in control fibroblasts about 4-fold higher than in the patients. Hence, studies of the identified missense variants reveal surprisingly different functional consequences as the insoluble Ala216Asp variant leads to loss of function, whereas the Arg178Gln leads to increased enzyme activity. The reported patients have remarkably preserved cognition, and we propose that the increased enzyme activity of the Arg178Gln variant offers a protective effect on cognitive function. This study establishes the importance of UCHL1 in neurodegeneration, provides new mechanistic insight about ubiquitin processing, and underlines the complexity of the different roles of UCHL1.